Back to discover
Disease

Gallstones

Late-stage therapeutic developmentEmerging research
1
Publications
10
Clinical trials
2017
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

10 sponsors · 1 new · 0 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
10
All trials
2
Active
2
Late-stage
4
Completed
Recently completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Cholangiopancreatography, Endoscopic Retrograde1
Leading journals1
  • Gut1
Leading researchers7
  • Beckingham I1
  • El Sayed G1
  • Gurusamy K1
  • Sturgess R1
  • Webster G1
  • Williams E1
  • Young T1
Affiliations (unnormalised)6
  • Aintree University Hospital Liverpool1
  • Bournemouth Digestive Diseases Centre1
  • Nottingham University Hospitals NHS Trust1
  • The Princess of Wales Hospital1
  • University College Hospital1
  • University College London Medical School1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Solid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER, resulting in the condition of CHOLELITHIASIS. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin.

Identifiers
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.